You are here
Zen-Bio, Inc.
UEI: LQS2WJFBBUQ3
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Tuned stem cell extracellular vesicles are a novel chronic wound therapeutic
Amount: $1,996,911.00Project Summary The elderly population is rapidly increasing worldwide and those over 60 years old are expected to comprise 20% of the total population by 2050. These demographic changes will focus he ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health -
A Novel Human Primary Meibomian Gland Cell Platform for Dry Eye Therapeutics
Amount: $216,626.00Dry eye diseaseDEDaffects visual function and quality of lifeand it is estimated to be prevalent inof adults agedyears old or older worldwide with females representing two thirds of this populationMei ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Selective Tuning of Stem Cell Extracellular Vesicles as a Novel Therapy for Age-related Tendinopathy
Amount: $221,826.00Project Summary Chronic tendon injury and tendinopathy are extremely common and painful degenerative conditions whose prevalence reachesin adults overMost of these people don t seek surgical treatment ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Tuned stem cell extracellular vesicles as a novel chronic wound therapeutic
Amount: $223,180.00Project Summary The elderly population is rapidly increasing worldwide and those over years old are expected to comprise of the total population by These demographic changes will focus he ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
A novel class of anti-acne therapeutics
Amount: $224,999.00DESCRIPTION provided by applicant Acne Vulgaris is a common skin disorder that affects of the population typically teenagers and young adults Over million people in the US are affected by ...
SBIRPhase I2016Department of Health and Human Services National Institutes of Health -
Development and validation of a human brown adipocyte system
Amount: $1,499,548.00Project Summary The activation and recruitment of brown adipose tissue has become an exciting target in the fight against obesity and its related metabolic diseases Brown adipose tissue differs from ...
SBIRPhase II2016Department of Health and Human Services National Institutes of Health -
IGF OT IGF HIGH CONTENT SCREENING FOR HUMAN PRIMARY PANCREATIC CELL TYPE SPECIFIC TOXICANTS
Amount: $224,901.00Not Available
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Development and validation of a human brown adipocyte system
Amount: $224,320.00DESCRIPTION provided by applicant The activation and recruitment of brown adipose tissue has become an exciting target in the fight against obesity and its related metabolic diseases Brown adipose ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Development of a drug discovery platform for human islets
Amount: $1,754,814.00DESCRIPTION provided by applicant Diabetes and diabetes related co morbidities are at epidemic proportions and an enormous burden to our healthcare system Although there has been significant progr ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
Selective Fyn kinase inhibitors for treatment of metabolic disease
Amount: $1,498,715.00DESCRIPTION provided by applicant Metabolic diseases such as type diabetes T D obesity and their related co morbidities have reached epidemic proportions worldwide While progress continues to ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health
